Speakers will present the recommendations from the National Advisory Committee on Immunization’s (NACI) Seasonal Influenza Vaccine Statement 2019-2020, and the Association of Medical Microbiology and Infectious Disease (AMMI) Canada’s Guidance for Practitioners on the Use of Antiviral Drugs for Influenza.
Refugee women’s health is a matter of concern for public health practitioners across Canada. In this episode of Infectious Questions, Shivoan & Zeeshan are joined by Ziba Miab (a doctoral student at the University of Manitoba) who discusses key themes highlighted by refugee women navigating the Canadian healthcare system.
This webinar provides an overview to public health personnel on AMR surveillance in Canada and opportunities to use surveillance data to support public health planning, decision-making and response.
This February 2019 presentation explored ethical considerations of appropriate antibiotic prescribing of public health, primary care and specialist physicians, where there may be perceived tension between duty to individual patients and duty to avoid overuse of antimicrobials.
In this final episode of our series on syphilis and public health, we hear from Dr. Jared Bullard, a pediatric infectious disease specialist at the University of Manitoba and Children’s Hospital in Winnipeg. He discusses recent increases in cases of congenital syphilis, the risks it poses to a fetus, as well as prevention strategies.
In this podcast, Dr. Marcia Anderson, a medical officer of health and medical lead for the Winnipeg Regional Health Authority, discusses the determinants of syphilis transmission in Indigenous women and what public health and primary care providers can learn to slow or stop the progression of syphilis within this community.
In this podcast, Laverne Gervais, program coordinator at Ka Ni Kanichihk and a Sexual Health Educator, discusses the determinants of syphilis transmission in Indigenous women and what public health and primary care providers can learn to slow or stop the progression of syphilis within this community.
Summary of the National Advisory Committee on Immunization’s Seasonal Influenza Statement and the Association of Medical Microbiology and Infectious Disease Canada’s Treatment Recommendations for frontline healthcare practitioners and public health vaccine providers to help guide their practice.
Dr. Ian Gemmill presented on prevention of seasonal influenza, types of vaccines available and their effectiveness, new indications and available internet resources. Dr. Gerald Evans presented on the burden of seasonal influenza, the trends in recent years and the antiviral treatment recommendations.
Lyme disease is a prominent issue in the media these days and a matter of concern among public health practitioners in Canada. This episode, we look at Lyme’s risk of transmission and prevention strategies.
A mathematical model is a virtual experiment set up to test a hypothesis. It creates a controlled environment where complex relationships between biological, environmental, demographic and behavioural factors can be represented.
For public health, mathematical models can be used to test different “what if” scenarios and the results can help inform policy, programs and practice.
NCCID has released two new resources about modelling and public health. A new video, a partnership with NCCMT, introduces public health to modelling. As a companion piece, NCCID developed a case study of a Promising Practice of a collaboration between public health in Winnipeg and modelers in Toronto, to assess the benefits of new interventions to reduce syphilis infections in Winnipeg.
In this, the fifth in our ‘TB Talk’ series of episodes, we hear from Dr. Ryan Cooper, an infectious diseases specialist with Alberta Health Services. Here, Dr. Cooper speaks to how post-landing TB surveillance works in Canada (including some Alberta-specific challenges), plus the best approach to on-going follow-up. He also discusses how Alberta’s virtual TB clinic model has made a difference to rural, remote and Indigenous communities.
The fourth in our ‘TB Talk’ series, conversations from the most recent meeting of the North American Region of the International Union Against Tuberculosis. This episode, we hear from Dr. Dennis Falzon, a Medical Officer with the Stop TB Department at the World Health Organization in Geneva. Here, he discusses the WHO’s End TB Strategy, as well as the potential of new technologies to prevent and eliminate TB.